Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in

ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.0155 AUD -3.13% Market Closed
Market Cap: AU$31.6m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.0485 AUD with a low forecast of 0.0303 AUD and a high forecast of 0.063 AUD.

IPD Lowest Forecast
Wall Street Target
0.0303 AUD
95% Upside
IPD Average Forecast
Wall Street Target
0.0485 AUD
213% Upside
IPD Highest Forecast
Wall Street Target
0.063 AUD
306% Upside
Lowest
Price Target
0.0303 AUD
95% Upside
Average
Price Target
0.0485 AUD
213% Upside
Highest
Price Target
0.063 AUD
306% Upside
ImpediMed Ltd Competitors:
Price Targets
NTGR
NETGEAR Inc
60% Upside
RVSB
Riverview Bancorp Inc
30% Upside
ZIP
Ziprecruiter Inc
53% Upside
EXLS
Exlservice Holdings Inc
44% Upside
NTGR
NETGEAR Inc
60% Upside
RVSB
Riverview Bancorp Inc
30% Upside
ZIP
Ziprecruiter Inc
53% Upside
EXLS
Exlservice Holdings Inc
44% Upside

Revenue
Forecast

11% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
11% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

For the last 13 years the compound annual growth rate for ImpediMed Ltd's revenue is 11%. The projected CAGR for the next 3 years is 39%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss

What are analyst estimates?

See Also

Summary
IPD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPD stock valuation using valuation multiples.
Wall Street Estimates
IPD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPD's stock price target?
Price Target
0.0485 AUD

According to Wall Street analysts, the average 1-year price target for IPD is 0.0485 AUD with a low forecast of 0.0303 AUD and a high forecast of 0.063 AUD.

What is ImpediMed Ltd's Revenue forecast?
Projected CAGR
39%

For the last 13 years the compound annual growth rate for ImpediMed Ltd's revenue is 11%. The projected CAGR for the next 3 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 328,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett